| Secondary |
| Product Used For Unknown Indication |
20.8% |
| Rheumatoid Arthritis |
14.0% |
| Drug Use For Unknown Indication |
12.3% |
| Asthma |
6.0% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Pain |
4.3% |
| Immunosuppression |
4.0% |
| Wheezing |
3.7% |
| Urticaria |
3.4% |
| Antibiotic Therapy |
3.1% |
| Vomiting |
2.8% |
| Colitis Ulcerative |
2.6% |
| Hypertension |
2.6% |
| Influenza Like Illness |
2.6% |
| Arthralgia |
2.3% |
| Corneal Disorder |
2.3% |
| Emphysema |
2.3% |
| Eye Oedema |
2.3% |
| Immunosuppressant Drug Therapy |
2.3% |
| Multiple Sclerosis |
2.3% |
|
| Vomiting |
10.9% |
| Diabetic Ketoacidosis |
7.8% |
| Tremor |
7.8% |
| Wheezing |
7.8% |
| Weight Decreased |
6.3% |
| Weight Increased |
6.3% |
| Keratitis |
4.7% |
| Lacrimation Increased |
4.7% |
| Pain In Extremity |
4.7% |
| Pneumocystis Jiroveci Pneumonia |
4.7% |
| Sudden Death |
4.7% |
| Visual Disturbance |
4.7% |
| Blood Glucose Increased |
3.1% |
| Bronchitis |
3.1% |
| Cataract |
3.1% |
| Dyspnoea |
3.1% |
| Gastric Ulcer Haemorrhage |
3.1% |
| Ill-defined Disorder |
3.1% |
| Oedema |
3.1% |
| Pancytopenia |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.4% |
| Rheumatoid Arthritis |
19.7% |
| Drug Use For Unknown Indication |
10.6% |
| Hypertension |
4.5% |
| Crohn's Disease |
4.4% |
| Asthma |
4.0% |
| Pain |
3.9% |
| Prophylaxis |
3.9% |
| Multiple Sclerosis |
3.5% |
| Prophylaxis Against Graft Versus Host Disease |
3.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Immunosuppressant Drug Therapy |
2.0% |
| Osteoporosis |
1.8% |
| Depression |
1.7% |
| Immunosuppression |
1.7% |
| Liver Transplant |
1.6% |
| Antibiotic Prophylaxis |
1.5% |
| Blood Pressure |
1.5% |
| Bone Marrow Conditioning Regimen |
1.5% |
| Anxiety |
1.4% |
|
| Vomiting |
12.8% |
| Pyrexia |
7.8% |
| Oxygen Saturation Decreased |
7.3% |
| Platelet Count Decreased |
6.4% |
| Weight Decreased |
6.4% |
| Drug Ineffective |
5.5% |
| Rash |
5.0% |
| Sepsis |
5.0% |
| Pain |
4.6% |
| Pneumonia |
4.6% |
| Wheezing |
4.6% |
| Thrombocytopenia |
4.1% |
| Product Quality Issue |
3.7% |
| Urticaria |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Death |
3.2% |
| Dyspnoea |
3.2% |
| Acute Graft Versus Host Disease |
2.8% |
| Asthma |
2.8% |
| Dyspepsia |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
40.0% |
| Pain |
40.0% |
| Intervertebral Disc Protrusion |
20.0% |
|
| Intervertebral Disc Protrusion |
100.0% |
|
